Automation index
How much of a Pharmacovigilance officer’s job can AI already do?
An ADR case comes earlier. Calling it serious without staying quiet to the regulator do not.
This percentage does not predict how many people will lose their jobs.
Task comparison
IS WORK OVER?
Pharmacovigilance officer
27%
AI can already do 27% of this job.
#186 / 643
View rankingPharmacovigilance officer
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Case, the file and MedDRA.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Seriousness, the link and the one that does not fit.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
File, the AEMPS deadline and not delaying.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Signal, the aggregate and not playing it down.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The doctor, the ADR and not arguing the story.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
If it is serious, call it. And not staying quiet.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 12% | +1.9 |
| Total | 100% | 27% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- ADR
- MedDRA
- AEMPS
- safety signals
- seriousness
- causality
- case files
- regulatory deadlines
Sources for this job· O*NET 29-1051.00· ESCO/ISCO 2262
IS WORK OVER?
Hepatologist
27%
#158 / 643
View rankingHepatologist
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Labs, fibroscan and the stage.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Clinic, the drink and the one who denies it.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
Biopsy, the risk and not needling extra.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Antiviral, adherence and the one who quits.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The transplant board and not jumping to a yes.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
Call the liver, and talking to the family.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 12% | +1.9 |
| Total | 100% | 27% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- fibroscan
- liver biopsy
- hepatitis
- cirrhosis
- liver transplant
- antivirals
- liver clinic
- decompensation
Sources for this job· O*NET 29-1216.00· ESCO/ISCO 2212